Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Evaluation of combination therapy for Burkholderia cenocepacia lung infection in different in vitro and in vivo models.

Van den Driessche F, Vanhoutte B, Brackman G, Crabbé A, Rigole P, Vercruysse J, Verstraete G, Cappoen D, Vervaet C, Cos P, Coenye T.

PLoS One. 2017 Mar 1;12(3):e0172723. doi: 10.1371/journal.pone.0172723. eCollection 2017 Mar 1.

2.

Burkholderia cepacia Complex Regulation of Virulence Gene Expression: A Review.

Sousa SA, Feliciano JR, Pita T, Guerreiro SI, Leitão JH.

Genes (Basel). 2017 Jan 19;8(1). pii: E43. doi: 10.3390/genes8010043. Review.

3.

1H-NMR-Based Endometabolome Profiles of Burkholderia cenocepacia Clonal Variants Retrieved from a Cystic Fibrosis Patient during Chronic Infection.

Moreira AS, Lourenço AB, Sá-Correia I.

Front Microbiol. 2016 Dec 20;7:2024. doi: 10.3389/fmicb.2016.02024. eCollection 2016 Dec 20.

4.

Intrinsic Resistance of Burkholderia cepacia Complex to Benzalkonium Chloride.

Ahn Y, Kim JM, Kweon O, Kim SJ, Jones RC, Woodling K, Gamboa da Costa G, LiPuma JJ, Hussong D, Marasa BS, Cerniglia CE.

MBio. 2016 Nov 22;7(6). pii: e01716-16. doi: 10.1128/mBio.01716-16.

5.

Complete Genome Sequences for Three Chromosomes of the Burkholderia stabilis Type Strain (ATCC BAA-67).

Bugrysheva JV, Cherney B, Sue D, Conley AB, Rowe LA, Knipe KM, Frace MA, Loparev VN, Avila JR, Anderson K, Hodge DR, Pillai SP, Weigel LM.

Genome Announc. 2016 Nov 17;4(6). pii: e01294-16. doi: 10.1128/genomeA.01294-16.

6.

The temperate Burkholderia phage AP3 of the Peduovirinae shows efficient antimicrobial activity against B. cenocepacia of the IIIA lineage.

Roszniowski B, Latka A, Maciejewska B, Vandenheuvel D, Olszak T, Briers Y, Holt GS, Valvano MA, Lavigne R, Smith DL, Drulis-Kawa Z.

Appl Microbiol Biotechnol. 2017 Feb;101(3):1203-1216. doi: 10.1007/s00253-016-7924-7. Epub 2016 Oct 21.

7.

The Role of Bacterial Secretion Systems in the Virulence of Gram-Negative Airway Pathogens Associated with Cystic Fibrosis.

Depluverez S, Devos S, Devreese B.

Front Microbiol. 2016 Aug 30;7:1336. doi: 10.3389/fmicb.2016.01336. eCollection 2016 Aug 30. Review.

8.

Antibiotic resistance in Burkholderia species.

Rhodes KA, Schweizer HP.

Drug Resist Updat. 2016 Sep;28:82-90. doi: 10.1016/j.drup.2016.07.003. Epub 2016 Jul 30.

PMID:
27620956
9.

Candidate Essential Genes in Burkholderia cenocepacia J2315 Identified by Genome-Wide TraDIS.

Wong YC, Abd El Ghany M, Naeem R, Lee KW, Tan YC, Pain A, Nathan S.

Front Microbiol. 2016 Aug 22;7:1288. doi: 10.3389/fmicb.2016.01288. eCollection 2016 Aug 22.

10.

Understanding the Pathogenicity of Burkholderia contaminans, an Emerging Pathogen in Cystic Fibrosis.

Nunvar J, Kalferstova L, Bloodworth RA, Kolar M, Degrossi J, Lubovich S, Cardona ST, Drevinek P.

PLoS One. 2016 Aug 11;11(8):e0160975. doi: 10.1371/journal.pone.0160975. eCollection 2016 Aug 11.

11.

Prospects for subunit vaccines: Technology advances resulting in efficacious antigens requires matching advances in early clinical trial investment.

McClean S.

Hum Vaccin Immunother. 2016 Dec;12(12):3103-3106. doi: 10.1080/21645515.2016.1216287. Epub 2016 Aug 5.

PMID:
27494532
12.

Orderly Replication and Segregation of the Four Replicons of Burkholderia cenocepacia J2315.

Du WL, Dubarry N, Passot FM, Kamgoué A, Murray H, Lane D, Pasta F.

PLoS Genet. 2016 Jul 18;12(7):e1006172. doi: 10.1371/journal.pgen.1006172. eCollection 2016 Jul 18.

13.

Cyanide Toxicity to Burkholderia cenocepacia Is Modulated by Polymicrobial Communities and Environmental Factors.

Bernier SP, Workentine ML, Li X, Magarvey NA, O'Toole GA, Surette MG.

Front Microbiol. 2016 May 18;7:725. doi: 10.3389/fmicb.2016.00725. eCollection 2016 May 18.

14.

A Functional oriT in the Ptw Plasmid of Burkholderia cenocepacia Can Be Recognized by the R388 Relaxase TrwC.

Fernández-González E, Bakioui S, Gomes MC, O'Callaghan D, Vergunst AC, Sangari FJ, Llosa M.

Front Mol Biosci. 2016 May 3;3:16. doi: 10.3389/fmolb.2016.00016. eCollection 2016 May 3.

15.
16.

Comparative genome-wide analysis reveals that Burkholderia contaminans MS14 possesses multiple antimicrobial biosynthesis genes but not major genetic loci required for pathogenesis.

Deng P, Wang X, Baird SM, Showmaker KC, Smith L, Peterson DG, Lu S.

Microbiologyopen. 2016 Jun;5(3):353-69. doi: 10.1002/mbo3.333. Epub 2016 Jan 14.

17.

Exploring the genomic traits of fungus-feeding bacterial genus Collimonas.

Song C, Schmidt R, de Jager V, Krzyzanowska D, Jongedijk E, Cankar K, Beekwilder J, van Veen A, de Boer W, van Veen JA, Garbeva P.

BMC Genomics. 2015 Dec 24;16:1103. doi: 10.1186/s12864-015-2289-3.

18.

Environmental marine pathogen isolation using mesocosm culture of sharpsnout seabream: striking genomic and morphological features of novel Endozoicomonas sp.

Katharios P, Seth-Smith HM, Fehr A, Mateos JM, Qi W, Richter D, Nufer L, Ruetten M, Guevara Soto M, Ziegler U, Thomson NR, Schlapbach R, Vaughan L.

Sci Rep. 2015 Dec 7;5:17609. doi: 10.1038/srep17609.

19.

Whole-Genome Sequencing of Three Clonal Clinical Isolates of B. cenocepacia from a Patient with Cystic Fibrosis.

Miller RR, Hird TJ, Tang P, Zlosnik JE.

PLoS One. 2015 Nov 24;10(11):e0143472. doi: 10.1371/journal.pone.0143472. eCollection 2015 Nov 24.

20.

Tyrosine Phosphorylation and Dephosphorylation in Burkholderia cenocepacia Affect Biofilm Formation, Growth under Nutritional Deprivation, and Pathogenicity.

Andrade A, Tavares-Carreón F, Khodai-Kalaki M, Valvano MA.

Appl Environ Microbiol. 2015 Nov 20;82(3):843-56. doi: 10.1128/AEM.03513-15.

Supplemental Content

Support Center